Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Gliosarcoma × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 6 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Skin Neoplasms 1 Pancreatic Neoplasms 1 Neurofibromatosis 1 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 18 Radiotherapy 10 Bevacizumab 7 Radiation 4 Irinotecan 4 Erlotinib Hydrochloride 3 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3 carmustine, poliferprosan 20 drug combination 2 Radiotherapy, Intensity-Modulated 2 O(6)-benzylguanine 2 Gadolinium DTPA 2 Drug Therapy 2 Cilengitide 2 Chemotherapy, Adjuvant 2 Carmustine 2 Aminolevulinic Acid 2 vitespin 1 sargramostim 1 sapanisertib 1 poly ICLC 1 picropodophyllin 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 laromustine 1 imetelstat 1 gadobutrol 1 gadobenic acid 1 encorafenib 1 cediranib 1 capmatinib 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡